U.S. healthcare giant CVS suddenly announced that it plans to split its sprawling business empire, built over many years, into two companies.
On November 4, $CVS.US announced plans to separate its retail pharmacy business from its insurance, pharmacy benefit management, and other businesses, with the split expected to be completed in the first half of 2028.
After the announcement, the stock fell as much as 12.6%, to around $79.94.
More interestingly, CVS reported adjusted earnings per share of $2.09 for the third quarter, well above market expectations of $1.65.
Earnings beat expectations, yet the stock plunged.
Over the past two decades, CVS has continually expanded through acquisitions, growing from pharmacies into insurance and healthcare services in an effort to build a business spanning the entire healthcare value chain.
Now, however, the company has decided to split up again.
The decision reflects regulatory pressure, business complexity, and investors’ renewed scrutiny of how large, integrated healthcare groups should be valued.
Getting bigger does not necessarily mean a company will command a higher valuation in the capital markets.
$NVDAB $BTC
On November 4, $CVS.US announced plans to separate its retail pharmacy business from its insurance, pharmacy benefit management, and other businesses, with the split expected to be completed in the first half of 2028.
After the announcement, the stock fell as much as 12.6%, to around $79.94.
More interestingly, CVS reported adjusted earnings per share of $2.09 for the third quarter, well above market expectations of $1.65.
Earnings beat expectations, yet the stock plunged.
Over the past two decades, CVS has continually expanded through acquisitions, growing from pharmacies into insurance and healthcare services in an effort to build a business spanning the entire healthcare value chain.
Now, however, the company has decided to split up again.
The decision reflects regulatory pressure, business complexity, and investors’ renewed scrutiny of how large, integrated healthcare groups should be valued.
Getting bigger does not necessarily mean a company will command a higher valuation in the capital markets.
$NVDAB $BTC